Skip to content

Effectiveness of Two Repetitive Peripheral Magnetic Stimulation Protocols in Managing Upper Trapezius Myofascial Pain: A Single-Blinded Randomized Controlled Trial

Effectiveness of Two Repetitive Peripheral Magnetic Stimulation Protocols in Managing Upper Trapezius Myofascial Pain: A Single-Blinded Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250929011
Enrollment
66
Registered
2025-09-29
Start date
2025-10-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with upper trapezius myofascial pain syndrome rPMS, upper trapezius myofascial pain syndrome, Visual Analog Scale , Pressure Pain Threshold, Neck Disability Index

Interventions

The intervention uses a Peripheral Magnetic Stimulation device REMED Rehabilitation Medical Company Salus Talent Pro three Tesla two channel one to one thousand Hertz hand held transducer with circula
Active Comparator Device,Active Comparator Device
Experimental Group Protocol A Progressive-intensity and Trigger Point,Control Group Protocol B Progressive-intensity and Trigger Point

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 55 years 2. Patients diagnosed by a physician with myofascial pain syndrome at the neck shoulder region presenting with an active myofascial trigger point according to Simons criteria 3. Patients with upper trapezius muscle pain lasting three months or longer 4. Patients with a Visual Analog Scale pain score of 4 or higher 5. Patients who understand Thai and are able to read and write and complete questionnaires and comply with follow up 6. Patients who provide informed consent to participate in the study

Exclusion criteria

Exclusion criteria: 1. Patients with chronic cervical spondylosis cervical spondylolisthesis cervical deformities or scoliosis or C1 C2 dislocation and patients with neurological deficits such as radiculopathy or myelopathy or with abnormal upper motor neuron signs 2. Patients with neurological or neuromuscular diseases such as central nervous system disorders 3. Patients with cervical abnormalities including rheumatoid arthritis or other inflammatory arthritis of the cervical spine such as ankylosing spondylitis or systemic lupus erythematosus 4. Patients with cervical trauma or history of cervical surgery 5. Patients with uncontrolled comorbidities including unstable cardiovascular disease uncontrolled hypertension with blood pressure greater than or equal to 160 over 110 mmHg or uncontrolled diabetes with blood glucose less than 60 mg per dl or greater than or equal to 250 mg per dl 6. Pregnant or breastfeeding women 7. Patients with fibromyalgia 8. Patients with a history of surgery at the neck or shoulder that may affect treatment outcomes 9. Patients with implanted electronic devices or metallic implants such as a cardiac pacemaker or cerebral aneurysm clips 10. Patients with cancer or tumors at the cervical region 11. Patients who received PMS treatment within the past three months 12. Patients with adverse reactions to nonsteroidal anti inflammatory drugs

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale 0, 2, and 4 weeks The Visual Analog Scale VAS is a tool for assessing patient pain intensity using a straight line ranging from 0 no pain to 10 worst possible pain.

Secondary

MeasureTime frame
Pressure Pain Threshold 0, 2, and 4 weeks PPT assesses the maximum pressure a patient can tolerate at a specific body point. The value is recorded in kilograms or Newtons, with higher values indicating greater pain tolerance.

Countries

Thailand

Contacts

Public ContactThitirut Jongutchariya

Hatyai Hospital

t_jong@hotmail.com074273100

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026